US FDA Grants Emergency Use Authorization for Johnson & Johnson COVID-19 Vaccine

Johnson & Johnson-Janssen 'COVID-19' Vaccine
[Image source=Yonhap News]

[Asia Economy Reporter Baek Kyunghwan] The U.S. Food and Drug Administration (FDA) has granted emergency use authorization for Johnson & Johnson's (J&J) COVID-19 vaccine.

According to foreign media on the 28th, the FDA accepted the recommendation from its advisory committee, the Vaccines and Related Biological Products Advisory Committee (VRBPAC), which voted to approve the emergency use of J&J's COVID-19 vaccine.

The advisory committee unanimously recommended granting emergency use authorization for the J&J vaccine to be administered to American adults aged 18 and older.

With this, the U.S. has secured a third COVID-19 vaccine following Pfizer and Moderna. The J&J vaccine is known for the advantage of requiring only a single dose.

This content was produced with the assistance of AI translation services.